Idera Pharmaceuticals' Unattributed VC Round

Idera Pharmaceuticals raised a round of funding on August 20, 2003.

Idera Pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-th…

Articles about Idera Pharmaceuticals' Unattributed VC Round: